Multiple myeloma differential diagnosis

Revision as of 02:47, 27 November 2017 by Mmir (talk | contribs) (Mahshid)
Jump to navigation Jump to search

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma differential diagnosis

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma differential diagnosis

CDC on Multiple myeloma differential diagnosis

Multiple myeloma differential diagnosis in the news

Blogs on Multiple myeloma differential diagnosis

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Multiple myeloma must be differentiated from monoclonal gammopathy of undetermined significance (MGUS), isolated plasmacytoma of the bone, and extramedullary plasmacytoma.[1]

Differentiating Multiple Myeloma from other Diseases

  • The table below summarizes how to differentiate multiple myeloma from other conditions that cause similar presentation:[1]
Plasma Cell Neoplasm M Protein Type Pathology Clinical Presentation
MGUS IgG kappa or lambda; or IgA kappa or lambda <10% plasma cells in bone marrow Asymptomatic, with minimal evidence of disease (aside from the presence of an M protein)
Isolated plasmacytoma of bone IgG kappa or lambda; or IgA kappa or gamma Solitary lesion of bone; <10% plasma cells in marrow of uninvolved site Asymptomatic or symptomatic
Extramedullary plasmacytoma IgG kappa or lambda; or IgA kappa or gamma Solitary lesion of soft tissue in the nasopharynx, tonsils, or sinuses Asymptomatic or symptomatic
Multiple myeloma IgG kappa or lambda; or IgA kappa or gamma Often multiple lesions of bone Symptomatic
  • Another important differential diagnosis is that of widespread bony metastases. Findings that favor the diagnosis of bony metastases over that of multiple myeloma include:[2]
  • Bone metastases more commonly affect the vertebral pedicles rather than vertebral bodies.
  • Bone metastases rarely involve mandible and distal axial skeleton.
  • Although both entities have variable bone scan appearances (both hot and cold) unlike multiple myeloma, extensive bony metastases rarely have a normal appearance.
  • Multiple myeloma must also be differentiated from other causes of bone pain and fatigue such as:
Differential Diagnosis Similar Features Differentiating Features
Multiple myeloma
  • On physical examination, demonstrates diffuse bone pain and tenderness
  • On imaging studies, demonstrates osteolytic lesions in the bones
-
Osteoporosis
  • On physical examination, demonstrates acute musculoskletal pain, if fracture happened
  • On imaging studies, demonstrates severe decrease in BMD
Idiopathic transient osteoporosis of hip
  • On physical examination, demonstrates acute hip pain
  • On imaging studies, demonstrates sub-chondoral cortical loss and diffuse osteopenia of the femoral neck
  • On history, demonstrates mostly involvement of pregnant women and young men
  • On history, demonstrates to be self-limiting in 6-8 months
Osteomalacia
Scurvy
Osteogenesis imperfecta
Homocystinuria

Multiple myeloma must be differentiated from other causes of diabetes insipidus.

Type of DI Subclass Disease Defining signs and symptoms Lab/Imaging findings
Central Acquired Histiocytosis
  • CD1a and CD45 +
  • Interleukin-17 (ILITA)
Skull x-ray of a patient with Langerhan's histiocytosis showing lytic lesions - Case courtesy of Dr Hani Salam, Radiopaedia.org, rID: 9459
Craniopharyngioma
Brain MRI showing suprasellar mass consistent with the diagnosis of craniopharyngioma - Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 16812
Sarcoidosis
Contrast-enhanced patches in a patient previously diagnosed with lung sarcoidosis - Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 10930
Congenital Hydrocephalus Dilated ventricles on CT and MRI
Obstructive hydrocephalus showing dilated lateral ventricles - Case courtesy of Dr Paul Simkin, Radiopaedia.org, rID: 30453
Wolfram Syndrome (DIDMOAD)
Nephrogenic Acquired Drug-induced (demeclocycline, lithium)
Hypercalcemia
  • Ca levels greater than 11 meq/L
Hypokalemia
  • K levels less than 3meq/L on CBC
Multiple myeloma
Skeletal survey in a patient with multiple myeloma showing multiple lytic lesions - Case courtesy of A.Prof Frank Gaillard, Radiopaedia.org, rID: 7682
Sickle cell disease
Blood film showing the sickle cells - By Dr Graham Beards - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=18421017
Primary polydipsia Psychogenic
Gestational diabetes insipidus
Diabetes mellitus
  • Elevated blood sugar levels >126
  • Elevated HbA1c > 6.5

References

  1. 1.0 1.1 "Myeloma - SEER Stat Fact Sheets". Retrieved 17 February 2014.
  2. Multiple myeloma. Radiopaedia (2015)http://radiopaedia.org/articles/multiple-myeloma-1 Accessed on September, 20th 2015
  3. Ghosh KN, Bhattacharya A (1992). "Gonotrophic nature of Phlebotomus argentipes (Diptera: Psychodidae) in the laboratory". Rev Inst Med Trop Sao Paulo. 34 (2): 181–2. PMID 1340034.


Template:WikiDoc Sources